HK1206366A1 - 誘導針對所有登革熱病毒血清型的免疫性的疫苗及製造疫苗的方法 - Google Patents

誘導針對所有登革熱病毒血清型的免疫性的疫苗及製造疫苗的方法

Info

Publication number
HK1206366A1
HK1206366A1 HK15106951.7A HK15106951A HK1206366A1 HK 1206366 A1 HK1206366 A1 HK 1206366A1 HK 15106951 A HK15106951 A HK 15106951A HK 1206366 A1 HK1206366 A1 HK 1206366A1
Authority
HK
Hong Kong
Prior art keywords
vaccines
vaccine
creating
methods
dengue virus
Prior art date
Application number
HK15106951.7A
Other languages
English (en)
Inventor
沙龍‧艾森
斯克特‧
‧邁克爾
Original Assignee
Florida Gulf Coast University Board Of Trustees
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florida Gulf Coast University Board Of Trustees filed Critical Florida Gulf Coast University Board Of Trustees
Publication of HK1206366A1 publication Critical patent/HK1206366A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK15106951.7A 2011-10-25 2015-07-21 誘導針對所有登革熱病毒血清型的免疫性的疫苗及製造疫苗的方法 HK1206366A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161550982P 2011-10-25 2011-10-25
PCT/US2012/061893 WO2013063248A1 (en) 2011-10-25 2012-10-25 Vaccines and methods for creating a vaccine for inducing immunity to all dengue virus serotypes

Publications (1)

Publication Number Publication Date
HK1206366A1 true HK1206366A1 (zh) 2016-01-08

Family

ID=48168485

Family Applications (2)

Application Number Title Priority Date Filing Date
HK14112282.6A HK1198770A1 (zh) 2011-10-25 2014-12-05 用於誘導所有登革熱病毒血清型免疫的疫苗和製造疫苗方法
HK15106951.7A HK1206366A1 (zh) 2011-10-25 2015-07-21 誘導針對所有登革熱病毒血清型的免疫性的疫苗及製造疫苗的方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK14112282.6A HK1198770A1 (zh) 2011-10-25 2014-12-05 用於誘導所有登革熱病毒血清型免疫的疫苗和製造疫苗方法

Country Status (9)

Country Link
US (2) US20150265694A1 (zh)
EP (1) EP2771366A4 (zh)
CN (1) CN104736568A (zh)
BR (1) BR112014009887A2 (zh)
CR (1) CR20140189S (zh)
HK (2) HK1198770A1 (zh)
IN (1) IN2014CN03925A (zh)
SG (1) SG11201401733VA (zh)
WO (1) WO2013063248A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ628206A (en) 2012-02-16 2016-03-31 Vlp Therapeutics Llc Virus like particle composition
US9637532B2 (en) 2013-07-12 2017-05-02 Vlp Therapeutics, Llc Virus like particle comprising PD-1 antigen or PD-1 ligand antigen
US10385101B2 (en) 2014-08-08 2019-08-20 Vlp Therapeutics, Llc Virus like particle comprising modified envelope protein E3
WO2016021209A1 (en) 2014-08-08 2016-02-11 Vlp Therapeutics, Llc Virus like particle comprising modified envelope protein e3
KR102532832B1 (ko) 2014-09-11 2023-05-16 브이엘피 테라퓨틱스 인코포레이티드 플라비바이러스 바이러스 유사 입자
CN105732777B (zh) * 2016-05-05 2019-06-04 中国人民解放军军事医学科学院微生物流行病研究所 黄热病毒特异性检测抗原及其应用
US11793873B2 (en) * 2017-05-10 2023-10-24 University Of Massachusetts Bivalent dengue/hepatitis B vaccines
CN110343172B (zh) * 2018-04-04 2021-09-03 中国科学院微生物研究所 一种高灵敏度的黄热病毒人源单克隆抗体及其应用
CN109627294B (zh) * 2018-12-29 2020-10-09 四川大学 一种正确折叠的重组狂犬病毒g蛋白胞外段及其潜在应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2372991B (en) * 2001-03-09 2004-11-17 Fiocruz Fundacao Oswaldo Cruz Flavivirus expression vector
WO2002102828A2 (en) * 2001-06-01 2002-12-27 Acambis, Inc. Chimeric flavivirus vectors
CN101287490B (zh) * 2005-08-10 2013-04-24 阿坎姆比斯公司 对抗登革热病毒感染的疫苗接种

Also Published As

Publication number Publication date
US20150265694A1 (en) 2015-09-24
EP2771366A4 (en) 2015-06-03
SG11201401733VA (en) 2014-09-26
EP2771366A1 (en) 2014-09-03
HK1198770A1 (zh) 2015-07-31
IN2014CN03925A (zh) 2015-07-03
WO2013063248A1 (en) 2013-05-02
BR112014009887A2 (pt) 2017-04-25
US10124053B2 (en) 2018-11-13
CR20140189S (es) 2014-09-24
CN104736568A (zh) 2015-06-24
US20170202945A1 (en) 2017-07-20

Similar Documents

Publication Publication Date Title
IL262123A (en) Influenza virus vaccines and their uses
HK1206366A1 (zh) 誘導針對所有登革熱病毒血清型的免疫性的疫苗及製造疫苗的方法
IL261204A (en) Influenza virus vaccines and their use
HK1199211A1 (zh) 流感病毒疫苗及其用途
IL229307A0 (en) Inactivated dengue virus vaccine
EP2552479A4 (en) INFLUENZA VIRUS VACCINES AND USES THEREOF
PL2935313T3 (pl) Szczepionki przeciwko wirusowi zapalenia wątroby typu b
EP2726097A4 (en) HERPES VIRUS VACCINE AND METHOD OF USE
IL231043A (en) vaccine
HK1197189A1 (zh) 犬冠狀病毒疫苗
PL2755680T3 (pl) Preparaty szczepionkowe w postaci cząstek
GB201119999D0 (en) Vaccine
HUE059179T2 (hu) Vízimadárban Mycoplasma-fertõzés megelõzésére szolgáló oltóanyag
EP2694102A4 (en) PROCESS FOR IMPROVED VACCINE IMMUNOGENICITY
EP2763699A4 (en) VACCINE
EP2678043A4 (en) RECOMBINANT MUMPSVIRUS VACCINE
SG10201702292YA (en) Novel attenuated dengue virus strains for vaccine application
ZA201503036B (en) Chimeric vaccine antigens against hepatitis c virus
EP2870238A4 (en) COMPOSITIONS AND METHODS ASSOCIATED WITH VIRAL VACCINES
EP2929894A4 (en) VACCINE ADJUVANS, PREPARATION AND VACCINES THEREOF
HK1201283A1 (zh) 丙型流感病毒和疫苗
EP2753686A4 (en) BIVALENT IPNV ISAV VACCINE USING A VIRUS LIKE PARTICLE PLATFORM AND USE METHOD THEREFOR
GB201120000D0 (en) Vaccine
EP2777712A4 (en) AUXILIARY SUBSTANCES FOR POLYSACCHARIDIVES AND FORMULATIONS OBTAINED THEREFROM
SG11201505170WA (en) Dengue virus vaccine composition